• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

FDA phasing out some animal testing in ‘win-win’ for ethics and public health: commissioner

by April 10, 2025
written by April 10, 2025

— The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA announced on Thursday. 

‘For too long, drug manufacturers have performed additional animal testing of drugs that have data in broad human use internationally. This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use,’ FDA Commissioner Martin A. Makary, said in comment provided to Fox News Digital. 

 ‘By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices. It is a win-win for public health and ethics.’ 

The phase-out focuses on ending animal testing in regard to researching monoclonal antibody therapies, which are lab-made proteins meant to stimulate the immune system to fight diseases such as cancer, as well as other drugs, according to the press release. 

Instead, the FDA will encourage testing on ‘organoids,’ which are artificially grown masses of cells, according to the FDA’s press release obtained by Fox Digital. 

‘The FDA will promote the use of lab-grown human ‘organoids’ and organ-on-a-chip systems that mimic human organs – such as liver, heart, and immune organs – to test drug safety. These experiments can reveal toxic effects that could easily go undetected in animals, providing a more direct window into human responses,’ the press release says. 

The FDA will also encourage the use of AI while testing drugs, including building computer modeling that can predict a drug’s behavior, Fox Digital learned. 

The phase-out will include updating its guidelines to recognize research conducted on organoids and through AI.

‘Companies that submit strong safety data from non-animal tests may receive streamlined review, as the need for certain animal studies is eliminated, which would incentivize investment in modernized testing platforms,’ the FDA explained in its press release. 

The FDA is slated to also work with fellow federal agencies, such as the National Institutes of Health, the National Toxicology Program and the Department of Veterans Affairs, to ‘accelerate the validation’ of the new testing standards and will hold a public workshop later this year to further discuss the matter. 

‘For patients, it means a more efficient pipeline for novel treatments. It also means an added margin of safety, since human-based test systems may better predict real-world outcomes. For animal welfare, it represents a major step toward ending the use of laboratory animals in drug testing. Thousands of animals, including dogs and primates, could eventually be spared each year as these new methods take root,’ Makary said. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
The great airlift: how Apple ferried 1.5M iPhones from India to the US to beat Trump tariffs
next post
American Airlines flight carrying US lawmakers ‘bumped’ by second plane on tarmac in DC

related articles

James Comer praises Kash Patel for ‘holding deep...

August 22, 2025

Trump DOJ to begin handing over Epstein files...

August 22, 2025

TikTok isn’t enough to stop Gen Z from...

August 22, 2025

Trump administration wins Supreme Court fight to slash...

August 22, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Pentagon unveils new medal for troops deployed in...

August 21, 2025

Federal judge rules Trump appointee Alina Habba is...

August 21, 2025

‘Maine’s Mamdani’: Maine GOP chief issues warning about...

August 21, 2025

‘There are 50 swamps’: State Freedom Caucus Network...

August 21, 2025

Trump-aligned legal group probes Biden-era organ transplant program...

August 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Saudi fighter jets escort Air Force One as Trump arrives to meet crown prince

    May 13, 2025
  • Nvidia hit a $4 trillion market valuation

    November 20, 2024
  • ‘Squad’ Dem Ayanna Pressley trashes Elon Musk, calling him a ‘Nazi nepo baby’

    February 5, 2025
  • India’s market cap falls below $4 trillion: what’s behind the slump?

    February 14, 2025
  • Iran becoming ‘much more aggressive’ in nuclear talks, Trump tells Fox News

    June 10, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,786)
  • Investing (634)
  • Stock (894)

Latest Posts

  • ApeCoin and Akita Inu: ApeCoin remains bearish today

    August 29, 2024
  • Egypt reportedly releases details on plan to rebuild Gaza; there’s no mention of ‘cooperation’ with the US

    February 13, 2025
  • Comer calls out Biden’s ‘failure’ to get federal employees to return to the office, vows to get it done

    January 16, 2025

Recent Posts

  • ApeCoin and Akita Inu: ApeCoin drops to support again

    August 14, 2024
  • Next Big Cryptocurrency: 2024 Top Picks

    July 26, 2024
  • CleanSpark (CLSK) Stock: Soaring High, Buy or Beware?

    July 17, 2024

Editor’s Pick

  • GGP Share Price Continues Decline. Will It Recover Soon?

    August 7, 2024
  • Qualcomm unveils AI chips for data centres with Nvidia compatibility

    May 19, 2025
  • Disney wins the 2024 box office as year-end receipts offer a welcome boost

    January 16, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock